Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 291163011000036117 | tobramycin 20 mg / 2 mL injection, 2 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 291164011000036115 | tobramycin 20 mg/2 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tobramycin 20 mg/2 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| tobramycin 20 mg/2 mL injection, vial | Is a | tobramycin | true | Inferred relationship | Some | ||
| tobramycin 20 mg/2 mL injection, vial | has intended active ingredient | tobramycin | true | Inferred relationship | Some | 1702253310 | |
| tobramycin 20 mg/2 mL injection, vial | has Australian BoSS | tobramycin | true | Inferred relationship | Some | 1702253310 | |
| tobramycin 20 mg/2 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| tobramycin 20 mg/2 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1702253311 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tobramycin (DBL) 20 mg/2 mL injection, 2 mL vial | Is a | True | tobramycin 20 mg/2 mL injection, vial | Inferred relationship | Some | |
| tobramycin 20 mg/2 mL injection, 5 x 2 mL vials | has MPUU | True | tobramycin 20 mg/2 mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR